Sinopharm Weiqida Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CLAVULANATE POTASSIUM DILUTED 1:1 WITH SILICON DIOXIDE, with a corresponding US DMF Number 27966.
Remarkably, this DMF maintains an Active status since its submission on March 12, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 08, 2014, and payment made on March 31, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II